— e.g. “Disruption of the manufacture of the drug.” (Canada)
supply-chain disruption — e.g. “Delay in shipping of the drug.” (Canada)
causes not stated by the regulator
Recent shortage history
Iceland: resolved 18 Jun 2026 (began 1 Mar 2026)
Iceland: resolved 18 Jun 2026 (began 12 Feb 2026)
Iceland: resolved 12 Jan 2026 (began 12 Sept 2025)
Iceland: resolved 10 Feb 2025 (began 8 Jan 2025)
Iceland: resolved 27 Sept 2024 (began 30 Aug 2024)
Iceland: resolved 11 Oct 2024 (began 19 Aug 2024)
Frequently asked questions
Is Tramadol Hydrochloride currently in shortage?
Yes. As of the latest regulator updates, Tramadol Hydrochloride has 5 active shortage notices across 2 countries (United States, Canada). Status is refreshed daily from official regulatory sources.
Why is Tramadol Hydrochloride in shortage?
Regulators attribute the current Tramadol Hydrochloride shortages to manufacturing problems, supply-chain disruption, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Tramadol Hydrochloride shortage be resolved?
Regulator-estimated resolution dates currently range from 10 May 2026 to 26 Jun 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Tramadol Hydrochloride shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Tramadol Hydrochloride status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.